SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-19-015361
Filing Date
2019-07-29
Accepted
2019-07-29 19:01:09
Documents
2
Period of Report
2019-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1788
2 POWER OF ATTORNEY poa_yabannavar.htm EX-24 7839
  Complete submission text file 0001567619-19-015361.txt   11017
Mailing Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Issuer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GRITSTONE ONCOLOGY, INC. 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address
Yabannavar Vijay (Reporting) CIK: 0001782619 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38663 | Film No.: 19982819